Related Experiment Video
Updated: Jun 1, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Consequences of succinylcholine administration to patients using statins
Alparslan Turan1, Maria L Mendoza, Shipra Gupta
1Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio, USA. alparslanturan@yahoo.com
Patients taking statins experienced higher myoglobin levels after succinylcholine, but this did not significantly increase muscle pain or other biomarkers. The impact of succinylcholine on statin users appears minimal.
Area of Science:
- Anesthesiology
- Pharmacology
- Muscle Physiology
Background:
- Statins can cause muscle damage (myotoxicity, myopathy, myalgias).
- Patients on statins may be more vulnerable to muscle injury from succinylcholine.
- This study investigated succinylcholine's effects in statin users versus non-users.
Purpose of the Study:
- To determine if succinylcholine increases myoglobin, potassium, and creatine kinase more in statin users.
- To assess if statin use exacerbates succinylcholine-induced postoperative muscle pain.
Main Methods:
- Compared 38 statin users with 32 non-users.
- Administered succinylcholine for intubation during general anesthesia.
- Measured plasma myoglobin, potassium, creatine kinase, and muscle pain (myalgia).
Main Results:
- Myoglobin levels at 20 minutes were higher in statin users (P=0.018).
- Fasciculations were more intense in statin users (P=0.047).
- Potassium, creatine kinase, and muscle pain were similar between groups.
Conclusions:
- Statin users showed a small, likely not clinically significant, increase in myoglobin post-succinylcholine.
- Succinylcholine's effects in patients taking statins are probably minor and of limited clinical consequence.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...